Literature DB >> 28336376

Effect of anesthetics on microglial activation and nanoparticle uptake: Implications for drug delivery in traumatic brain injury.

Gokul Kannan1, Siva P Kambhampati2, Sapna R Kudchadkar3.   

Abstract

Traumatic brain injury (TBI) is a serious public health problem, often with devastating consequences for patients and their families. Affordable and timely therapies can have a substantial impact on outcomes in severe TBI. Despite the common use of sedatives and anesthetics in the acute phase of TBI management, their effect on glial cells is not well understood. We investigated the effect of a commonly used sedative, pentobarbital, on glial cells and their uptake of nanoparticles. First, we studied how pentobarbital affects BV2 mouse microglial cells in culture. The cell morphology was imaged by confocal microscopy and analyzed. Our results suggest that microglia change to a more swollen, 'activated' shape with pentobarbital (cell area increased by approximately 20%, p<0.001). Such glial activation may have negative implications for the ability of the injured brain to clear edema. Second, we investigated how pentobarbital treatment affected nanoparticle uptake. BV-2 mouse microglial cells in the presence and absence of pentobarbital were treated with fluorescently-labeled, hydroxyl-functionalized poly(amidoamine) dendrimer nanoparticles (Dendrimer-Cy5). We demonstrated that the presence of pentobarbital increased the dendrimer nanoparticle uptake significantly (~2-fold both 2 and 6h following treatment). This semi-quantitative fluorescence assessment was broadly consistent among confocal image analysis, flow cytometry, and fluorescence quantification of cell-extracted dendrimer-Cy5. Although anesthetics appear to activate microglia, the increased uptake of dendrimer nanoparticles in their presence can be exploited to deliver drug-loaded nanoparticles directly to microglia after TBI. These drugs could restore glial and glymphatic function, enabling efficient drainage of waste and fluid from the brain and effectively improving recovery after TBI. A key future direction is to validate these findings in TBI models.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28336376     DOI: 10.1016/j.jconrel.2017.03.032

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  8 in total

1.  Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy.

Authors:  Bela R Turk; Christina L Nemeth; Joel S Marx; Carol Tiffany; Richard Jones; Benjamin Theisen; Siva Kambhampati; Raj Ramireddy; Sarabdeep Singh; Melissa Rosen; Miriam L Kaufman; Connor F Murray; Paul A Watkins; Sujatha Kannan; Rangaramanujam Kannan; Ali Fatemi
Journal:  Ann Neurol       Date:  2018-09       Impact factor: 10.422

2.  Leveraging the Dynamic Blood-Brain Barrier for Central Nervous System Nanoparticle-based Drug Delivery Applications.

Authors:  Connor Copeland; Sarah E Stabenfeldt
Journal:  Curr Opin Biomed Eng       Date:  2020-04-14

3.  Governing Transport Principles for Nanotherapeutic Application in the Brain.

Authors:  Hawley Helmbrecht; Andrea Joseph; Michael McKenna; Mengying Zhang; Elizabeth Nance
Journal:  Curr Opin Chem Eng       Date:  2020-10-18       Impact factor: 5.163

4.  Imaging techniques in nanomedical research.

Authors:  Laura Calderan; Manuela Malatesta
Journal:  Eur J Histochem       Date:  2020-07-01       Impact factor: 3.188

5.  Preferential and Increased Uptake of Hydroxyl-Terminated PAMAM Dendrimers by Activated Microglia in Rabbit Brain Mixed Glial Culture.

Authors:  Yossef Alnasser; Siva P Kambhampati; Elizabeth Nance; Labchan Rajbhandari; Shiva Shrestha; Arun Venkatesan; Rangaramanujam M Kannan; Sujatha Kannan
Journal:  Molecules       Date:  2018-04-27       Impact factor: 4.411

6.  Scalable synthesis and validation of PAMAM dendrimer-N-acetyl cysteine conjugate for potential translation.

Authors:  Rishi Sharma; Anjali Sharma; Siva P Kambhampati; Rajsekar Rami Reddy; Zhi Zhang; Jeffrey L Cleland; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Bioeng Transl Med       Date:  2018-05-25

Review 7.  Glymphatic System: Emerging Therapeutic Target for Neurological Diseases.

Authors:  Xianjun Xuan; Guoyi Zhou; Caihong Chen; Anwen Shao; Yunxiang Zhou; Xiaobo Li; Jiaqi Zhou
Journal:  Oxid Med Cell Longev       Date:  2022-06-11       Impact factor: 7.310

Review 8.  Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Chin J Traumatol       Date:  2018-04-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.